$0.6193
0.01933.22%
Last update: Oct 27, 1:36 PM
Standard BioTools Inc (LAB) Stock Price, Quote, News & History
LABNASDAQ
Illumina will acquire SomaLogic to expand in proteomics, adding new revenue streams and accelerating tech development in multiomics.
You can purchase shares of Standard BioTools (NASDAQ:LAB) through any online brokerage.
Other companies in Standard BioTools’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Standard BioTools has a consensus price target of $2.37.
The stock price for Standard BioTools (NASDAQ: LAB) is $0.6193 last updated October 27, 2026 at 1:36 PM EDT.
There are no upcoming dividends for Standard BioTools.
Standard BioTools does not have any upcoming earnings scheduled.
There is no upcoming split for Standard BioTools.
Standard BioTools is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and...
